| CASE REPORT |
|
| Year : 2014 | Volume
: 5
| Issue : 3 | Page : 214-216 |
|
|
Angioedema due to fixed dose combination of telmisartan plus ramipril
Vishal R Tandon1, Annil Mahajan2, Vijay Khajuria1, Zahid H Gillani1
1 Department of Pharmacology and Therapeutic, Government Medical College, Jammu, Jammu and Kashmir, India
2 Department of General Medicine, Government Medical College, Jammu, Jammu and Kashmir, India
Correspondence Address:
Vishal R Tandon
Department of Pharmacology and Therapeutic, Adverse Drug Reaction Monitoring Centre (Under PvPI), Government Medical College, Jammu - 180 001, Jammu and Kashmir
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0976-500X.136113
|
|
|
The risk for angioedema has been suggested lower with angiotensin receptor blockers (ARBs) than with angiotensin-converting enzyme inhibitors (ACEIs) or aliskiren. Many isolated reports do exist, reporting angioedema with ARBs such as olmesartan, valsartan, losartan and telmisartan. To the best of our knowledge this is the first case report of telmisartan plus ramipril fixed dose combination leading to angioedema from India questioning the rationality of ARBs plus ACEIs combination in the treatment of hypertension. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
